BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23370512)

  • 21. Development of PET probes for cancer imaging.
    Huang R; Wang M; Zhu Y; Conti PS; Chen K
    Curr Top Med Chem; 2015; 15(8):795-819. PubMed ID: 25732787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Imaging in Drug Discovery and Development.
    Lindner JR; Link J
    Circ Cardiovasc Imaging; 2018 Feb; 11(2):e005355. PubMed ID: 29449411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug interaction studies on new drug applications: current situations and regulatory views in Japan.
    Nagai N
    Drug Metab Pharmacokinet; 2010; 25(1):3-15. PubMed ID: 20208385
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches using molecular imaging technology -- use of PET in clinical microdose studies.
    Wagner CC; Langer O
    Adv Drug Deliv Rev; 2011 Jun; 63(7):539-46. PubMed ID: 20887762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dual-Modality Activity-Based Probes as Molecular Imaging Agents for Vascular Inflammation.
    Withana NP; Saito T; Ma X; Garland M; Liu C; Kosuge H; Amsallem M; Verdoes M; Ofori LO; Fischbein M; Arakawa M; Cheng Z; McConnell MV; Bogyo M
    J Nucl Med; 2016 Oct; 57(10):1583-1590. PubMed ID: 27199363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging as a tool in drug development.
    Strack T
    Drugs Today (Barc); 2007 Oct; 43(10):725-36. PubMed ID: 17987225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent applications of positron emission tomographic (PET) imaging in psychiatric drug discovery.
    Zimmer L
    Expert Opin Drug Discov; 2024 Feb; 19(2):161-172. PubMed ID: 37948046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Utilization of population pharmacokinetics in drug development and provision of the results to healthcare professionals
.
    Watanabe-Uchida M; Narukawa M
    Int J Clin Pharmacol Ther; 2017 Jan; 55(1):25-31. PubMed ID: 27841154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Translational PET imaging research.
    Hargreaves RJ; Rabiner EA
    Neurobiol Dis; 2014 Jan; 61():32-8. PubMed ID: 24055214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Regulatory Science in the Review of Drugs and Medical Devices].
    Koide A
    Yakugaku Zasshi; 2016; 136(4):557-62. PubMed ID: 27040338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiopharmaceuticals: molecular imaging using positron emission tomography.
    Antoni G; Långström B
    Handb Exp Pharmacol; 2008; (185 Pt 1):177-201. PubMed ID: 18626804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Developing new molecular imaging probes for PET.
    Serdons K; Verbruggen A; Bormans GM
    Methods; 2009 Jun; 48(2):104-11. PubMed ID: 19318126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Contribution of molecular imaging research to innovative drug development].
    Shimada H
    Rinsho Shinkeigaku; 2014; 54(12):1174-7. PubMed ID: 25672737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography microdosing: a new concept with application in tracer and early clinical drug development.
    Bergström M; Grahnén A; Långström B
    Eur J Clin Pharmacol; 2003 Sep; 59(5-6):357-66. PubMed ID: 12937873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Future direction of renal positron emission tomography.
    Szabo Z; Xia J; Mathews WB; Brown PR
    Semin Nucl Med; 2006 Jan; 36(1):36-50. PubMed ID: 16356795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Application of pharmacokinetics-pharmacodynamics/clinical response modeling and simulation for biologics drug development.
    Zhao L; Shang EY; Sahajwalla CG
    J Pharm Sci; 2012 Dec; 101(12):4367-82. PubMed ID: 23018763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. INDs for PET molecular imaging probes-approach by an academic institution.
    Mosessian S; Duarte-Vogel SM; Stout DB; Roos KP; Lawson GW; Jordan MC; Ogden A; Matter C; Sadeghi S; Mills GQ; Schelbert HR; Radu CG; Czernin J; Couto M; Phelps ME
    Mol Imaging Biol; 2014 Aug; 16(4):441-8. PubMed ID: 24733693
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Target engagement in lead generation.
    Durham TB; Blanco MJ
    Bioorg Med Chem Lett; 2015 Mar; 25(5):998-1008. PubMed ID: 25630223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small animal PET imaging.
    Hutchins GD; Miller MA; Soon VC; Receveur T
    ILAR J; 2008; 49(1):54-65. PubMed ID: 18172333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.